Pharmacokinetics Study in Rats

CB Comfort A. Boateng
* *
# #
AN Ashley N. Nilson
# #
RP Rebekah Placide
MP Mimi L. Pham
FJ Franziska M. Jakobs
NB Noelia Boldizsar
SM Scot McIntosh
LS Leia S. Stallings
IK Ivana V. Korankyi
SK Shreya Kelshikar
NS Nisha Shah
DP Diandra Panasis
AM Abigail Muccilli
ML Maria Ladik
BM Brianna Maslonka
CM Connor McBride
MS Moises Ximello Sanchez
EA Ebrar Akca
MA Mohammad Alkhatib
JS Julianna Saez
CN Catherine Nguyen
EK Emily Kurtyan
JD Jacquelyn DePierro
RC Raymond Crowthers
DB Dylan Brunt
AB Alessandro Bonifazi
AN Amy Hauck Newman
RR Rana Rais
BS Barbara S. Slusher
RF R. Benjamin Free
DS David R. Sibley
KS Kent D. Stewart
CW Chun Wu
SH Scott E. Hemby
TK Thomas M. Keck
* *
ask Ask a question
Favorite

Pharmacokinetic studies in Sprague–Dawley (SD) rats were conducted according to protocols approved by the Animal Care and Use Committee at Johns Hopkins University. SD rats obtained from Harlan were maintained on a 12 h light–dark cycle with ad libitum access to food and water. A test compound was administered via i.p. injection at a dose of 10 mg/kg (100% saline vehicle, 10 mL/kg volume). The rats were sacrificed at specified time points (0.25, 0.5, 1, 2, 4, and 6 h) post drug administration. For the collection of plasma and brain tissue, animals were euthanized with CO2 and blood samples were collected in heparinized microtubes by cardiac puncture. Brains were dissected and immediately flash-frozen (−80 °C). Blood samples were spun at 2000g for 15 min, and the plasma was removed and stored at −80 °C until analysis (as described below).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A